Tobacco Smoke Exposure Limits the Therapeutic Benefit of Tezacaftor/Ivacaftor in Pediatric Patients with Cystic Fibrosis by Gabriela Oates, Ph.D., assistant professor, Steven Rowe, M.D., professor, and Tom Harris, M.D., associate professor in the Division of Pediatric Pulmonology, has been selected as Best of Journal of Cystic Fibrosis for 2020.
The paperDr. Oates presented the article in a special session, “Best of Journal of Cystic Fibrosis, The Lancet Respiratory Medicine, and European Respiratory Journal” at the European Cystic Fibrosis Society (ECFS) annual meeting in early June 2021. Each journal selects one paper to highlight at the conference.
Congratulations to Drs. Oates, Rowe and Harris!